The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InModular Medical, Inc. (NASDAQ: MODD) has announced the pricing of a registered direct offering involving 750,000 shares of its common stock at a price of $4.50 per share. The company expects to generate gross proceeds of approximately $3.4 million, before accounting for placement agent fees and other offering expenses. This capital raise follows closely on the heels of the company receiving FDA clearance for its Pivot insulin pump just five days ago. The funds are likely earmarked to support the commercialization phase of its medical devices and general corporate operations. While the influx of capital is vital for growth, direct offerings often exert downward pressure on stock prices due to share dilution. Investors are closely monitoring how the company utilizes these funds to scale its market presence in the insulin delivery sector.